Feixiang Wu

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion

Jiazhou Ye, Jun-Ze Chen, Zihui Li et al. · World Journal of Gastroenterology · 2017 · 98 citations · Full text

Medicine, Oncology, Perioperative Medicine +17

Starvation‐induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF‐β1/Smad3‐mediated epithelial‐mesenchymal transition activation

Hang Tong, Hubin Yin, Mohammad Arman Hossain et al. · Journal of Cellular Biochemistry · 2018 · 80 citations

Life Sciences, Cell Biology, Oncology +15

Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer

Shasha Wu, Feixiang Wu, Zheng Jiang · Oncology Reports · 2017 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +17

Repeat hepatic resection <i>versus</i> radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study

Jian‐Hong Zhong, Anthony W.H. Chan, Charing C. N. Chong et al. · British journal of surgery · 2021 · 48 citations

Medicine, Oncology, Surgery +15